|
| [January 10, 2013] |
 |
Josef von Rickenbach of PAREXEL International Elected 2013 ACRO Chairman
WASHINGTON --(Business Wire)--
The Association
of Clinical Research Organizations is pleased to announce that its
Board of Directors has elected Josef von Rickenbach, founder, Chairman
and CEO of PAREXEL
International, as 2013 Chairman and Ciaran Murray, CEO of ICON,
as Vice Chairman.
"I am pleased to again lead an organization whose members contribute to
the development of virtually every new medical product that benefits
patients worldwide," said Mr. von Rickenbach. "ACRO and its members play
a leading role in advocating for a sound global regulatory environment
to promote safe, ethical, high-quality clinical research. At the same
time, we are engaged with our clients, regulators, patient groups and
other stakeholders to drive innvation in the drug development process."
Mr. von Rickenbach is a founding Board member of ACRO and this is his
second term as Chairman. Also elected as officers were: Diarmaid
Cunningham, General Counsel of ICON, as Secretary; and James Winschel,
CFO of PAREXEL, as Treasurer.
Recognizing the growing need to balance the free flow of research data
with individual privacy concerns, ACRO also announced the formation of a
Global Data Protection and Privacy Committee, chaired by Uwe Fiedler,
Global Privacy Officer at PAREXEL.
"With a growing emphasis on the use of 'big data' in research, privacy
continues to be an area of focus for global CROs operating in Europe,
the United States and other regions," said Doug Peddicord, PhD,
Executive Director of ACRO. "This committee joins other permanent ACRO
committees that focus on regulatory and scientific affairs, research
ethics, legal and government affairs, and communications. We look
forward to working with Josef, Ciaran and the ACRO membership as we
tackle these important issues in 2013."
About ACRO
The Association
of Clinical Research Organizations (ACRO) represents companies that
provide a variety of specialized services that support the development
of new pharmaceuticals, biologics and medical devices. The association
provides an active voice for the CRO industry globally. Through its
member companies, ACRO helps improve the quality, efficiency and safety
of biomedical research. ACRO member companies employ approximately
75,000 professionals worldwide and annually conduct more than 11,000
clinical trials involving nearly two million participants in 115
countries. For more information, please visit www.acrohealth.org.
Twitter (News - Alert) @acrohealth.
YouTube (News - Alert) @ACROHealthChannel.

[ Back To Technology News's Homepage ]
|